# Maintenance Treatment Versus Observation After Induction in Advanced Colorectal Carcinoma

> **NCT00442637** · PHASE3 · UNKNOWN · sponsor: **Dutch Colorectal Cancer Group** · enrollment: 635 (estimated)

## Conditions studied

- Colorectal Cancer Metastatic

## Interventions

- **DRUG:** capecitabine + bevacizumab
- **OTHER:** observation

## Key facts

- **NCT ID:** NCT00442637
- **Lead sponsor:** Dutch Colorectal Cancer Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** 2013-09
- **Final completion:** 2013-12
- **Target enrollment:** 635 (ESTIMATED)
- **Last updated:** 2013-12-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00442637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00442637, "Maintenance Treatment Versus Observation After Induction in Advanced Colorectal Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00442637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*